Health Canada
- Status: approved
Inavtivated Quadrivalent Influenza Virus Split Vaccine (Inavtivated Quadrivalent Influenza Virus Split Vaccine) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Wuhan Institute of Biological Products Co., Ltd is the originator. The local marketing authorisation holder may differ — check the official source linked above.